NK cell activity depends on the interplay between inhibitory receptors for major histocompatibility complex (MHC) class I molecules and activating receptors, such as NKG2D and DNAM-1 that operate in concert to induce the elimination of tumor cells [29, 30]. The gene discussed is KLRK1; the disease is neoplasm.